IPO of APONTIS PHARMA AG in the Frankfurt Stock Exchange’s Scale segment

Release date: 11 May 2021 | Deutsche Börse Cash Market

IPO of APONTIS PHARMA AG in the Frankfurt Stock Exchange’s Scale segment

APONTIS PHARMA AG (ISIN: DE000A3CMGM5) has been listed in the Scale Segment on the Frankfurt Stock Exchange since today. The shares had an initial listing price of €18.90. The issue price was €19.00.

The IPO was accompanied by Hauck & Aufhäuser and M.M. Warburg. Hauck & Aufhäuser also acts as designated sponsor on Xetra. Specialist on the trading venue Börse Frankfurt is Wolfgang Steubing AG.

According to its own information, APONTIS PHARMA AG is a leading pharmaceutical company in Germany that specialises in single pills. Single pills combine two to three generic active ingredients in one combination preparation. Last year, the company, headquartered in Monheim am Rhein, achieved a turnover of over €39 million.

Market Status




Parts of the trading system are currently experiencing technical issues

The trading system is currently experiencing technical issues

Xetra newsboard

The market status window is an indication regarding the current technical availability of the trading system. It indicates whether news board messages regarding current technical issues of the trading system have been published or will be published shortly.

We strongly recommend not to take any decisions based on the indications in the market status window but to always check the production news board for comprehensive information on an incident.

An instant update of the Market Status requires an enabled up-to date Java™ version within the browser.